These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30797617)

  • 21. Reply to Silvia Selinski, Daniel Ovsiannikov, Jan G. Hengstler and Klaus Golka's Letter to the editor re: Caroline E. Weibull, Sandra Eloranta, Daniel Altman, Anna L.V. Johansson, Mats Lambe. Childbearing and the risk of bladder cancer: a nationwide population-based cohort study. Eur Urol 2013;63:733-8.
    Weibull CE; Eloranta S; Johansson AL; Altman D; Lambe M
    Eur Urol; 2013 Oct; 64(4):e81. PubMed ID: 23743136
    [No Abstract]   [Full Text] [Related]  

  • 22. Re: Rodolfo Montironi, Silvia Gasparrini, Roberta Mazzucchelli, et al's Letter to the Editor re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738-9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides. Eur Urol 2017;71:e73-5.
    Iczkowski KA
    Eur Urol; 2017 Aug; 72(2):e36. PubMed ID: 28284740
    [No Abstract]   [Full Text] [Related]  

  • 23. Simultaneous Bilateral Endoscopic Surgery (SBES) for Bilateral Urolithiasis: the Future? Evidence from a Systematic Review.
    Geraghty RM; Jones P; Somani BK
    Curr Urol Rep; 2019 Feb; 20(3):15. PubMed ID: 30790070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reply to Hao Lun Luo, Yen Ta Chen, Yuan Tso Cheng, and Po Hui Chiang's Letter to the Editor re: Re: Thomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, et al. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel. Eur Urol 2016;70:1052-68: The Key Role of Flexible Ureterorenoscopy in Kidney-sparing Surgery for Upper Tract Urothelial Carcinoma.
    Seisen T; Babjuk M; Rouprêt M
    Eur Urol; 2017 Apr; 71(4):e111-e112. PubMed ID: 27666997
    [No Abstract]   [Full Text] [Related]  

  • 25. Reply to Letter to Editor Re: Endoscopic Management of Urolithiasis in the Horseshoe Kidney.
    Blackburne AT; Krambeck AE
    Urology; 2016 Sep; 95():222-3. PubMed ID: 27237778
    [No Abstract]   [Full Text] [Related]  

  • 26. Reply to Jae Heon Kim's Letter to the Editor re: Mauro Gacci, Giovanni Corona, Arcangelo Sebastianelli, et al. Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis. Eur Urol 2016;70:788-96.
    Gacci M; Vignozzi L; Corona G; Serni S; Maggi M
    Eur Urol; 2017 Apr; 71(4):e119-e120. PubMed ID: 27816298
    [No Abstract]   [Full Text] [Related]  

  • 27. Re: Christian Türk, Aleš Petřík, Kemal Sarica, et al. EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis. Eur Urol 2016;69:468-74: Magnetic Resonance Urography Can be Used to Detect Urinary Stones.
    Sudah M
    Eur Urol; 2016 Apr; 69(4):e76-e77. PubMed ID: 26614549
    [No Abstract]   [Full Text] [Related]  

  • 28. Reply to Daniela Wittmann, Ted A. Skolarus' Letter to the Editor re: Neil E. Martin, Laura Massey, Caleb Stowell, et al. Defining a Standard Set of Patient-centered Outcomes for Men with Localized Prostate Cancer. Eur Urol 2014;67:460-7.
    Martin NE; Stowell C
    Eur Urol; 2016 Jun; 69(6):e127. PubMed ID: 26873843
    [No Abstract]   [Full Text] [Related]  

  • 29. Reply from authors re: Brian R. Matlaga. How do we manage infected, obstructed hydronephrosis? Eur Urol 2013;64:93-4: the infected upper urinary tract stone and obstruction: stent first where possible?
    Ghani KR; Sammon JD; Trinh QD
    Eur Urol; 2013 Jul; 64(1):95-6. PubMed ID: 23159453
    [No Abstract]   [Full Text] [Related]  

  • 30. Reply to Weigang Yan, Zhien Zhou, Hanzhong Li's Letter to the Editor re: Jeffrey J. Tosoian, Debasish Sundi, Bruce J. Trock, et al. Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery. Eur Urol 2016;69:576-81.
    Tosoian JJ; Trock BJ; Ballentine Carter H; Mamawala M
    Eur Urol; 2017 Jan; 71(1):e13. PubMed ID: 27311363
    [No Abstract]   [Full Text] [Related]  

  • 31. Reply to Jae Hung Jung, Julia L. Han, and Philipp Dahm's Letter to the Editor re: Vasileios I. Sakalis, Markos Karavitakis, Dina Bedretdinova, et al. Medical Treatment of Nocturia in Men with Lower Urinary Tract Symptoms: Systematic Review by the European Association of Urology Guidelines Panel for Male Lower Urinary Tract Symptoms. Eur Urol 2017;72:757-69.
    Sakalis VI; Gravas S; Drake MJ
    Eur Urol; 2018 Mar; 73(3):e60-e62. PubMed ID: 29233662
    [No Abstract]   [Full Text] [Related]  

  • 32. Reply to Yan Shibing and Wei Qiang's Letter to the Editor re: Morgan Rouprêt, Marko Babjuk, Eva Compérat, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. Eur Urol 2015;68:868-79.
    Rouprêt M
    Eur Urol; 2016 Mar; 69(3):e51-2. PubMed ID: 26461109
    [No Abstract]   [Full Text] [Related]  

  • 33. Reply to Maxine G. Tran, Ravi Barod, and Axel Bex's Letter to the Editor re: Philip S. Macklin, Mark E. Sullivan, Charles R. Tapping, et al. Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre. Eur Urol 2019;75:861-7.
    Macklin PS; Sullivan ME; Tapping CR; Webster GM; Roberts ISD; Verrill CL; Browning L
    Eur Urol; 2019 Jun; 75(6):e177-e178. PubMed ID: 30827695
    [No Abstract]   [Full Text] [Related]  

  • 34. Reply to Giulia I. Lane and Badrinath Konety's Letter to the Editor re: Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4.
    Bhindi B; Boorjian SA
    Eur Urol; 2018 Mar; 73(3):e70-e71. PubMed ID: 29097100
    [No Abstract]   [Full Text] [Related]  

  • 35. Reply to Georgios Papadopoulos, Charalampos Fragkoulis, and Konstantinos Ntoumas' Letter to the Editor re: Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4.
    Bhindi B; Boorjian SA
    Eur Urol; 2018 Mar; 73(3):e53. PubMed ID: 29246642
    [No Abstract]   [Full Text] [Related]  

  • 36. Reply to Erik Rud and Eduard Baco's Letter to the Editor re: Re: Jeffrey C. Weinreb, Jelle O. Barentsz, Peter L. Choyke, et al. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol 2016;69:16-40.
    Barentsz JO; Choyke PL; Cornud F; Haider MA; Macura KJ; Margolis D; Shtern F; Padhani AR; Tempany CM; Thoeny HC; Verma S; Weinreb JC
    Eur Urol; 2016 Nov; 70(5):e137-e138. PubMed ID: 27130148
    [No Abstract]   [Full Text] [Related]  

  • 37. Reply to Francesco Massari and Vincenzo Di Nunno's Letter to the Editor re: Jose Luis Perez-Gracia, Yohann Loriot, Jonathan E. Rosenberg, et al. Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Outcomes by Prior Number of Regimens. Eur Urol 2018;73:462-8.
    Perez-Gracia JL
    Eur Urol; 2018 Jul; 74(1):e14. PubMed ID: 29656856
    [No Abstract]   [Full Text] [Related]  

  • 38. Reply to E. Jason Abel Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660-73.
    Marconi L; Lam TB; Bex A; Ljungberg B; Volpe A
    Eur Urol; 2016 Jun; 69(6):e119-20. PubMed ID: 26776936
    [No Abstract]   [Full Text] [Related]  

  • 39. Reply to Lu Yang, Shi Qiu and Qiang Wei's Letter to the Editor re: Christopher E. Bayne, Stephen B. Williams, Matthew R. Cooperberg, et al. Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives. Eur Urol 2016;69:775-87.
    Bayne CE; Williams -B; Chapin BF
    Eur Urol; 2017 Feb; 71(2):e51. PubMed ID: 27461403
    [No Abstract]   [Full Text] [Related]  

  • 40. Reply to Arjen Noordzij and Gert van Dijk's letter to the editor re: Walter Artibani, Vincenzo Ficarra, Ben J. Challacombe, et al. EAU policy on live surgery events. Eur urol 2014;66:87-97.
    Artibani W; Parsons K
    Eur Urol; 2014 Dec; 66(6):e120. PubMed ID: 25151014
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.